Esperion Therapeutics, Inc. Information Request Form
Company
Esperion Therapeutics, Inc.
Ticker
ESPR
Levi & Korsinsky announces it has commenced an investigation of Esperion Therapeutics, Inc. (NASDAQ: ESPR) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.